Interaction and Antiviral Treatment of Coinfection between SARS-CoV-2 and Influenza in Vitro
CONCLUSIONS: In coinfection, the replication of SARS-CoV-2 would be interfered by influenza H1N1. Compared with molnupiravir or baloxavir monotherapy, treatment with a combination of molnupiravir and baloxavir should be considered for early treatment in patients with SARS-CoV-2 and influenza coinfection.PMID:38621598 | DOI:10.1016/j.virusres.2024.199371
Source: Virus Research - Category: Virology Authors: Danlei Liu Ka-Yi Leung Hoi-Yan Lam Ruiqi Zhang Yujing Fan Xiaochun Xie Kwok-Hung Chan Ivan Fan-Ngai Hung Source Type: research
More News: Coronavirus | COVID-19 | Flu Pandemic | H1N1 | Influenza | Pandemics | Respiratory Medicine | SARS | Virology